article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027. health care: “Wake up, public health!” Health Populi’s Hot Points: Life expectancy in the U.S.

article thumbnail

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

Year-on-year, different spikes and ups-and-downs call out for special mention, such as: Pharma’s 13-point steep dive to 38% between 2017 and 2018, dramatically recovering by 9 points in the last year to 47% [with the wild card here of whether U.S. Hospitals’ fall from 70% to 63% between 2018 and 2019.

BioTech 310
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Americans’ Trust in the Healthcare System Low Compared to Rest-of-World’s Health Citizens

Health Populi

I covered the launch of the 2018 Edelman Trust Barometer across all industries here in Health Populi in January 2018 , when this year’s annual report was presented at the World Economic Forum in Davos as it is each year. Biotech is roughly tied for second place with consumer health, dropping also by 7 points.

BioTech 185
article thumbnail

Spring 2019: Healthcare Updates to Know

Advanced Medical Reviews

Sharpless is a proponent of big data and previously founded two biotech companies. CMS Publishes New National Health Expenditures Data. The Center for Medicare & Medicaid Services has posted new data on projected national health expenditures for 2018-2027. percent of the country’s GDP in 2027, including a 4.8

BioTech 66
article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

Increasingly, as patients bear more first-dollar costs through high-deductible health plans, co-payments and co-insurance sharing, the patient-as-payor has become more sensitive to these prices. Chan School of Public Health with POLITICO looked into Americans’ Health and Education Priorities for the New Congress in 2019.

BioTech 160
article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. 2 Digital health is a large (+$900bn by 2032) and growing (13.6%

article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

That logic was bolstered by a finding in the 2018 Edelman Trust Barometer finding more U.S. consumers trusted the biotech health industry segment compared with the pharmaceutical segment. Most health citizens, hoping for a way out of the public health crisis, are counting on science to liberate both lives and livelihoods.